Almutairi, A. R., Alkhatib, N. S., Oh, M., Curiel-Lewandrowski, C., Babiker, H. M., Cranmer, L. D., . . . Abraham, I. (2018). Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma. JAMA Dermatol.
Citação norma ChicagoAlmutairi, Abdulaali R., Nimer S. Alkhatib, Mok Oh, Clara Curiel-Lewandrowski, Hani M. Babiker, Lee D. Cranmer, Ali McBride, and Ivo Abraham. "Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy Vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma." JAMA Dermatol 2018.
MLA citiranjeAlmutairi, Abdulaali R., et al. "Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy Vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma." JAMA Dermatol 2018.